Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Glenda Stone"'
Autor:
Stephen O. Bader, Xavier F. Marinaro, Glenda Stone, Kunal Lodaya, Jeffrey B. Spears, Aryeh Shander
Publikováno v:
Heliyon, Vol 9, Iss 9, Pp e19497- (2023)
Background: Heparin resistance is a common complication of surgical patients requiring anticoagulation, such as those undergoing cardiopulmonary bypass (CPB). Treatments to address heparin resistance include supplementation of antithrombin (AT) or fr
Externí odkaz:
https://doaj.org/article/cae5575356b6424dba4c38c60dcbbad4
Autor:
Christopher M. Blanchette, Joshua M. Noone, Glenda Stone, Emily Zacherle, Ripsi P. Patel, Reuben Howden, Douglas Mapel
Publikováno v:
Medical Sciences, Vol 5, Iss 4, p 20 (2017)
Non-cystic fibrosis bronchiectasis (NCFBE) is a rare, chronic lung disease characterized by bronchial inflammation and permanent airway dilation. Chronic infections with P. aeruginosa have been linked to higher morbidity and mortality. To understand
Externí odkaz:
https://doaj.org/article/0360a6a3585444feb75a646ab606a3dd
Autor:
Glenda Stone, Charlie Strange, Christopher M. Blanchette, Robert A. Sandhaus, M. Chris Runken, Reuben Howden
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 15:2389-2397
Introduction Alpha-1 antitrypsin deficiency (AATD) is often not identified in patients with chronic obstructive pulmonary disease (COPD) until advanced stages of disease, despite the availability of genetic testing. While clinical practice guidelines
Publikováno v:
D21. HEALTH CARE QUALITY AND UTILIZATION IN PATIENTS WITH COPD.
Autor:
Reuben Howden, E Zacherle, Christopher M. Blanchette, Glenda Stone, Joshua M Noone, D Mapel, RP Patel
Publikováno v:
C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT.
Publikováno v:
Advances in Therapy
Introduction Alpha 1-antitrypsin deficiency (AATD) is a genetic disorder which reduces serum alpha 1-antitrypsin (AAT or alpha1-proteinase inhibitor, A1PI) and increases the risk of chronic obstructive pulmonary disease (COPD). Management strategies
Autor:
Adam T. Hill, Pieter Goeminne, Michal Shteinberg, Melissa J. McDonnell, Simon Finch, Stefano Aliberti, Dusanka Obradovic, Thomas C. Fardon, Angela Davis, Anthony De Soyza, James D. Chalmers, Glenda Stone, Marion Trautmann, Katerina Dimakou, Eva Polverino
Publikováno v:
Respiratory Infections.
Introduction: Chronic infection with Pseudomonas aeruginosa is recognised by bronchiectasis guidelines as a poor prognostic factor and a trigger for consideration of prophylactic antibiotic treatment. The prevalence and burden of P. aeruginosa chroni
Autor:
Reuben Howden, D Mapel, Christopher M. Blanchette, MC Runken, Joshua M Noone, Glenda Stone, E Zacherle
Publikováno v:
Pneumologie. 70
Autor:
MC Runken, E Zacherle, Joshua M Noone, Reuben Howden, Christopher M. Blanchette, Glenda Stone, D Mapel
Publikováno v:
Pneumologie. 70
Autor:
Dusanka Obradovic, Thomas C. Fardon, Marion Trautmann, Stefano Aliberti, Pieter Goeminne, James D. Chalmers, Glenda Stone, David Araújo, Katerina Dimakou, Michal Shteinberg, Melissa J. McDonnell, Adam T. Hill, Angela Davis, Anthony De Soyza, Eva Polverino
Publikováno v:
European Respiratory Journal. 51:1701953
Pseudomonas aeruginosa is responsible for chronic infection in many bronchiectasis patients but it is not known whether it is associated with worse clinical outcomes independent of the underlying severity of disease.This study analysed data from 2596